LATANOPROST Mepha gtt opht 50 mcg/ml fl 2.5 ml
7680606120048
CH-60612
S01EE01
11.09.0.
1 / 3
google
Details
- Product number
- 6061201
- CPT
- -
- Packaging group
- 1 x 2,5
- Unit
- ml
- Composition
- latanoprostum 50 µg, natrii dihydrogenophosphas monohydricus et dinatrii phosphas corresp. phosphas 6.34 mg, natrii chloridum, aqua purificata, benzalkonii chloridum 0.2 mg, ad solutionem pro 1 ml.
Articles (1)
Latanoprost-Mepha, Augentropfen
Augentropfen
1 x 2,5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
6.34 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.2 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 27.25
Specialties list
Yes
Generic
Yes
SL addition date:
01/10/2011
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 60612
- Drug name
- Latanoprost-Mepha, Augentropfen
- Galenic form
- AUGT
- ATC Code
- S01EE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/10/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 11.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LATANOPROST Mepha gtt opht 50 mcg/ml fl 2.5 ml
- Description (DE)
- LATANOPROST Mepha Gtt Opht 50 mcg/ml Fl 2.5 ml
- Market launch
- 12/10/2010
- Narcotic (BTM)
- No